SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001126234-22-000114
Filing Date
2022-11-18
Accepted
2022-11-18 16:31:44
Documents
1
Period of Report
2022-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166880708979109.html 4  
1 FORM 4 wf-form4_166880708979109.xml 4 4095
  Complete submission text file 0001126234-22-000114.txt   5603
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Issuer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXVET BIOPHARMA PLC NATL INST, FOSTERS AVENUE, MOUNT MERRION BLACKROCK L2 00000
Business Address
McCracken Joseph S (Reporting) CIK: 0001632454 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35342 | Film No.: 221402356